Brief: Supriya Lifescience Approved Capital Expenditure Plan At Ambernath Site For CDMO Facility
07/02/2024 12:54
Feb 7 (Reuters) - Supriya Lifescience Ltd SPRL.NS :
* APPROVED CAPITAL EXPENDITURE PLAN AT AMBERNATH SITE FOR
CDMO
FACILITY
Source text for Eikon: ID:nNSEcbtVL5
Further company coverage: SPRL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supriya Lifescience
See all newsBrief: Supriya Lifescience Says Court Orders Provisional Release Of 200 KG Ketamine Hydrochloride Consignment
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit